Cardiome Pharma Corp.

Cardiome Pharma Corp.

Sector: Pharmaceutical Preparations Region: Canada

: | Nasdaq: CRME | Toronto Stock Exchange: COM

Similar to: BioGaia AB, Sareum Holdings Plc, Hutchison China MediTech Ltd.

Cardiome Pharma Corp. is a biopharmaceutical company, which engages in the discovery, development and commercialization of new therapies that will improve the health of patients around the world. Its product BrinavessTM approved in Europe and other territories for the rapid conversion of recent onset atrial fibrillation to sinus rhythm in adults. Cardiome Pharma was founded on December 12, 1986 and is headquartered in Vancouver, Canada.

News & Analysis

You may also be interested in: